Article
Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Dec 2017
Smyth Elizabeth, Zhang Shenli, Cunningham David, Wotherspoon Andrew, Soong Richie, Peckitt Clare, Valeri Nicola, Fassan Matteo, Rugge Massimo, Okines Alicia, Allum William, Stenning Sally, Nankivell Matthew, Langley Ruth, Tan Patrick
Abstract excerpt
Purpose: Germline polymorphisms may affect chemotherapy efficacy and toxicity. We examined the effect of polymorphisms in drug metabolism and DNA repair genes on pathologic response rates, survival, and toxicity for patients randomized to surgery alone or perioperative ECF chemotherapy in the MRC MAGIC trial.Experimental Design: DNA was extracted from nontumor resection formalin-fixed paraffin-embedded (FFPE)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
